Thrombocytopenia

At Montefiore Einstein Hematology (Blood Disorders), you can access exceptional care for thrombocytopenia. As a global leader in hematology, we are an academic-based, national and international referral site for the most complex and high-risk cases. For over a century, we have been at the forefront of innovation, research and clinical care for all types of blood disorders.

Our team of world-renowned hematologists is passionate about uncovering the latest diagnostic approaches and treatments that can improve outcomes.

At Montefiore Einstein Hematology (Blood Disorders), you can expect compassionate, personalized, research-driven treatment plans that meet the highest standards for quality and safety. By combining innovative therapies with proactive patient outreach, we strive to elevate the standard of care and significantly enhance outcomes for those living with thrombocytopenia.

When you need thrombocytopenia care, turn to our dedicated providers who will develop a highly personalized treatment plan.

Thrombocytopenia can be classified based on its underlying cause:

• Primary thrombocytopenia, such as immune thrombocytopenia purpura (ITP), occurs when the immune system mistakenly attacks platelets.
• Secondary thrombocytopenia results from other conditions, including infections, liver disease, bone marrow disorders and medication side effects.
• Inherited thrombocytopenia is caused by genetic disorders affecting platelet production.

Understanding the type of thrombocytopenia is essential for developing a targeted treatment approach.

Several factors can lead to thrombocytopenia, including reduced platelet production in the bone marrow, increased platelet destruction or excessive platelet sequestration in the spleen. Conditions such as leukemia, aplastic anemia and myelodysplastic disorders can impair platelet production. Autoimmune diseases, such as lupus and ITP, may cause the immune system to destroy platelets. An enlarged spleen, often caused by liver disease or blood cancers, can trap platelets, reducing their availability in circulation. Certain medications, including chemotherapy, can also contribute to thrombocytopenia.

Symptoms of thrombocytopenia vary depending on severity. Many individuals experience easy bruising, prolonged bleeding from minor cuts, frequent nosebleeds and bleeding gums. Some develop a red or purple pinpoint rash (petechiae) on the skin. In severe cases, internal bleeding may occur, leading to symptoms such as blood in the urine or stool, prolonged menstrual bleeding or, in rare cases, life-threatening brain hemorrhages.

Diagnosis begins with a complete blood count (CBC) to measure platelet levels. Additional tests may include reviewing the peripheral blood smear, checking vitamin levels, evaluating for viral infections, blood clotting tests, ultrasound of the abdomen and, in some cases, bone marrow biopsy and genetic testing to identify underlying disorders. Identifying the precise cause of thrombocytopenia is crucial for effective treatment.

Treatment for thrombocytopenia depends on its cause and severity. Mild cases may require monitoring without immediate intervention. ITP is often managed with corticosteroids, immunosuppressants or platelet-stimulating agents. Severe thrombocytopenia with active bleeding may necessitate platelet transfusions. If an enlarged spleen contributes to platelet loss, a splenectomy (surgical removal of the spleen) may be considered. For thrombocytopenia caused by medications or infections, adjusting treatment regimens or addressing underlying infections may restore normal platelet levels. Montefiore Einstein Hematology (Blood Disorders) provides access to cutting-edge therapies and clinical trials, ensuring the best possible outcomes for patients.